Novo Nordisk Aktie
59,12
EUR
-1,76
EUR
-2,89
%
59,42
EUR
-0,58
EUR
-0,97
%
Werbung
Novo Nordisk Aktie Analyse
04.02.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
04.02.19 | Novo Nordisk buy | Deutsche Bank AG | |
01.02.19 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
01.02.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
01.02.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
28.01.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
22.01.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
21.01.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
Werbung
|
|||
11.01.19 | Novo Nordisk buy | Deutsche Bank AG | |
03.01.19 | Novo Nordisk Outperform | Bernstein Research | |
02.01.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
10.12.18 | Novo Nordisk buy | Deutsche Bank AG | |
30.11.18 | Novo Nordisk buy | UBS AG | |
26.11.18 | Novo Nordisk buy | UBS AG | |
23.11.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
23.11.18 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
19.11.18 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
05.11.18 | Novo Nordisk buy | UBS AG | |
02.11.18 | Novo Nordisk buy | Deutsche Bank AG | |
02.11.18 | Novo Nordisk Conviction Buy | Goldman Sachs Group Inc. | |
01.11.18 | Novo Nordisk buy | UBS AG | |
26.10.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
10.10.18 | Novo Nordisk buy | UBS AG | |
10.10.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
08.10.18 | Novo Nordisk buy | Deutsche Bank AG | |
05.10.18 | Novo Nordisk buy | UBS AG | |
04.10.18 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
20.08.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
09.08.18 | Novo Nordisk buy | Deutsche Bank AG | |
09.08.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
08.08.18 | Novo Nordisk buy | UBS AG | |
08.08.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
25.07.18 | Novo Nordisk buy | UBS AG | |
23.07.18 | Novo Nordisk Outperform | Bernstein Research | |
11.07.18 | Novo Nordisk buy | Deutsche Bank AG | |
11.07.18 | Novo Nordisk Conviction Buy | Goldman Sachs Group Inc. | |
02.07.18 | Novo Nordisk Outperform | Bernstein Research | |
28.06.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
28.06.18 | Novo Nordisk buy | Deutsche Bank AG | |
25.06.18 | Novo Nordisk buy | UBS AG | |
21.06.18 | Novo Nordisk buy | Deutsche Bank AG | |
21.06.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
14.06.18 | Novo Nordisk buy | UBS AG | |
08.06.18 | Novo Nordisk buy | UBS AG | |
30.05.18 | Novo Nordisk overweight | Morgan Stanley | |
30.05.18 | Novo Nordisk buy | UBS AG | |
30.05.18 | Novo Nordisk buy | Deutsche Bank AG | |
29.05.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
08.05.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
03.05.18 | Novo Nordisk buy | Deutsche Bank AG |
Werbung
Werbung